Education
About Us
Working with TipRanks
Follow Us
Pulse Biosciences (PLSE)
NASDAQ:PLSE
Earnings Data
Report Date
Mar 26, 2026After Close (Confirmed)
Period Ending
2025 (Q4)Consensus EPS Forecast
-0.32Last Year’s EPS
-0.17Same Quarter Last Year
Moderate Buy
Based on 1 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Neutral
The earnings call highlighted significant progress in clinical trials and regulatory approvals, promising initial revenues, and positive clinical outcomes. However, the financials showed increased costs and cash usage, resulting in a higher net loss.Company Guidance
Progress in nPulse Vybrance System Adoption
The nPulse Vybrance percutaneous electrode system for soft tissue ablation showed strong product market fit in the pilot program. Over 200 patients have been treated, and procedure volumes increased sequentially this quarter.
Regulatory and Clinical Trial Advancements
Received FDA investigational device exemption approval for the nPulse cardiac surgery system for atrial fibrillation. Initiated NANOCLAMP AF study, the first PFA study approved by FDA for a surgical cardiac ablation device.
Positive Clinical Outcomes for nPulse 360 Catheter
Encouraging initial clinical outcomes from Europe for the nPulse 360 Catheter confirm its potential for advancing AF treatment. 150 patients enrolled in the ongoing feasibility study.
Initial Revenues Generated
Pulse Biosciences recognized initial revenues of $86,000 from nPulse capital and Vybrance disposable sales during the limited market release.
PLSE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
PLSE Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
Nov 05, 2025 | $16.27 | $15.73 | -3.32% |
Aug 12, 2025 | $15.10 | $16.79 | +11.19% |
May 08, 2025 | $16.85 | $17.07 | +1.31% |
Mar 27, 2025 | $15.66 | $16.60 | +6.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Pulse Biosciences (PLSE) report earnings?
Pulse Biosciences (PLSE) is schdueled to report earning on Mar 26, 2026, After Close (Confirmed).
What is Pulse Biosciences (PLSE) earnings time?
Pulse Biosciences (PLSE) earnings time is at Mar 26, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is PLSE EPS forecast?
PLSE EPS forecast for the fiscal quarter 2025 (Q4) is -0.32.